This topic contains a solution. Click here to go to the answer

Author Question: Which of the following ventilators is unaffected by the use of heliox, whatever the FIO2? a. ... (Read 45 times)

jho37

  • Hero Member
  • *****
  • Posts: 531
Which of the following ventilators is unaffected by the use of heliox, whatever the FIO2?
 
  a. Drger E-4
  b. Servo 300
  c. Hamilton Galileo
  d. Puritan Bennett 840

Question 2

The NAVA mode can be used in which of the following situations?
 
  a. Paralysis
  b. Heavy sedation
  c. Injury to the respiratory brain centers
  d. Spontaneous breathing



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

kardosa007

  • Sr. Member
  • ****
  • Posts: 300
Answer to Question 1

ANS: B

Answer to Question 2

ANS: D
The motivation for the development of neurally adjusted ventilatory assist (NAVA) was to allow the spontaneously breathing patient to have greater control of his or her tidal volume, TI and flow.




jho37

  • Member
  • Posts: 531
Reply 2 on: Jul 16, 2018
Thanks for the timely response, appreciate it


adammoses97

  • Member
  • Posts: 337
Reply 3 on: Yesterday
Great answer, keep it coming :)

 

Did you know?

Hyperthyroidism leads to an increased rate of metabolism and affects about 1% of women but only 0.1% of men. For most people, this increased metabolic rate causes the thyroid gland to become enlarged (known as a goiter).

Did you know?

Sperm cells are so tiny that 400 to 500 million (400,000,000–500,000,000) of them fit onto 1 tsp.

Did you know?

Interferon was scarce and expensive until 1980, when the interferon gene was inserted into bacteria using recombinant DNA technology, allowing for mass cultivation and purification from bacterial cultures.

Did you know?

In Eastern Europe and Russia, interferon is administered intranasally in varied doses for the common cold and influenza. It is claimed that this treatment can lower the risk of infection by as much as 60–70%.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

For a complete list of videos, visit our video library